Roll Call featured Ngor Luong in an article about the Biden administration's potential plan to screen and restrict U.S. investment in China's tech sector.

CSET’s Hanna Dohmen spoke with the South China Morning Post about the Cyberspace Administration of China's (CAC) draft regulations aimed at generative AI services like ChatGPT.

An article by Bloomberg Law referenced a report by CSET's Emily S. Weinstein and Ngor Luong.

An article published by Bloomberg cited a report by CSET’s Dahlia Peterson and CSET alumnus Saif M. Khan. The article discusses Japan’s efforts to boost its position in the global semiconductor market by significantly increasing its spending on chip gear.

CSET's Hanna Dohmen was quoted in an article published by University World News on competition between China and the United States in AI research.

Foreign Policy published an article about competition between the United States and China in the field of artificial intelligence, featuring insights from CSET's Emily S. Weinstein.

An article published by Voice of America quoted CSET's Jacob Feldgoise. Feldgoise states that the Chinese government intends to encourage Chinese scientists to make foreign chokepoints irrelevant by financing research in chokepoint technologies.

CSET's Emily S. Weinstein was quoted in an article published by Science that discusses China's new plan to achieve "self-reliance" in science and technology.

CBC News published an article about China's alleged interference in the political processes of other countries, featuring insights from Anna Puglisi, CSET Director of Biotechnology Programs and Senior Fellow, who explained the role of China's United Front Work Department (UFWD).

CSET Director of Biotechnology Programs and Senior Fellow Anna Puglisi provided insights into China's illicit efforts to acquire genetic data from the United States in Politico's Morning Cybersecurity. She pointed out that such data will serve a wide variety of interests, from health care to agriculture. “It’s enablers like sequencing and other tools of discovery that are going to drive the bioeconomy, that are going to drive precision medicine,” she said. “The more data you have, the more you can start to understand what genes do.”